PPARCCA for policy makers
The Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011 (PPARCCA), spearheaded by the National Psoriasis Foundation and its advocates, was introduced in Congress May 26, 2011. Sen. Robert Menendez (D-N.J.) introduced it in the Senate. Rep. Jim Gerlach (R-Pa.-6th) introduced it in the House of Representatives, with the support of Rep. Charles Gonzalez (D-Texas-20th).
The bill sheds light on the seriousness of psoriasis and psoriatic arthritis and advances the nation's efforts to find cures for these diseases If passed, the Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011 will:
- Secure $1.5 million a year (2012-2017) to continue the psoriasis data collection project.
The project began with $1.5 million allocated to the Centers for Disease Control and Prevention (CDC) by Congress in 2009. CDC researchers have completed the first phase of the project. Without continued funding, this initial investment will be lost. Learn more »
- NPF and others are bringing scientists from different disciplines together to study the connections between psoriatic disease and other serious health conditions.
PPARCCA calls on the National Institutes of Health to join these efforts—forming a strong public-private partnership to find a cure.
Learn more about S. 1107/H.R. 2033, the Psoriasis and Psoriatic Arthritis Research, Cure and Care Act of 2011